TAF
ALNY icon

Tredje AP-fonden’s Alnylam Pharmaceuticals ALNY Stock Holding History

Tredje AP-fonden’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.2M Sell
37,206
-12,388
-25% -$3.74M 0.05% 319
2026
Q1 		$16.4M Buy
49,594
+9,147
+23% +$3.11M 0.09% 216
2025
Q4 		$16.1M Buy
40,447
+26,991
+201% +$11.9M 0.12% 128
2025
Q3 		$6.14M Buy
13,456
+1,254
+10% +$511K 0.05% 145
2025
Q2 		$3.98M Sell
12,202
-3,705
-23% -$1.03M 0.03% 151
2025
Q1 		$4.3M Buy
15,907
+6,165
+63% +$1.58M 0.04% 161
2024
Q4 		$2.29M Sell
9,742
-9,741
-50% -$2.56M 0.02% 247
2024
Q3 		$5.36M Hold
19,483
– – 0.05% 198
2024
Q2 		$4.73M Sell
19,483
-308
-2% -$48.6K 0.05% 190
2024
Q1 		$2.96M Hold
19,791
– – 0.03% 288
2023
Q4 		$3.79M Sell
19,791
-765
-4% -$130K 0.05% 239
2023
Q3 		$3.64M Sell
20,556
-1,812
-8% -$346K 0.05% 230
2023
Q2 		$4.25M Sell
22,368
-3,720
-14% -$738K 0.06% 219
2023
Q1 		$5.23M Buy
26,088
+1,824
+8% +$383K 0.08% 175
2022
Q4 		$5.77M Buy
24,264
+422
+2% +$90K 0.1% 154
2022
Q3 		$4.77M Buy
+23,842
New +$4.55M 0.1% 154
2018
Q2 		– Sell
-7,200
Closed -$858K – 400
2018
Q1 		$858K Buy
7,200
+3,550
+97% +$458K 0.03% 444
2017
Q4 		$464K Buy
+3,650
New +$459K 0.02% 516

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Tredje AP-fonden's ALNY Position: Q2 2026 in Review

Tredje AP-fonden reduced its Alnylam Pharmaceuticals (ALNY) stake by 25% in Q2 2026, selling an estimated $3.74M and leaving 37,206 shares worth $11.2M. The position accounts for 0.05% of the portfolio, ranked #319.

Tredje AP-fonden first reported a position in ALNY in Q4 2017 and has held it in 18 quarters since. The position peaked at $16.4M in Q1 2026. 793 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

  • Tredje AP-fonden held 37,206 shares of Alnylam Pharmaceuticals worth $11.2M as of Q2 2026.
  • Tredje AP-fonden sold 12,388 Alnylam Pharmaceuticals shares in Q2 2026, an estimated $3.74M.
  • Alnylam Pharmaceuticals made up 0.05% of Tredje AP-fonden's portfolio in Q2 2026, its #319 holding.
  • Tredje AP-fonden first reported a position in Alnylam Pharmaceuticals in Q4 2017 and has held it in 18 quarters since.
  • Tredje AP-fonden's Alnylam Pharmaceuticals position peaked at $16.4M in Q1 2026.
  • 793 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on Tredje AP-fonden's 13F filing for Q2 2026, filed 10 Aug 2026.